Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 AUD | -6.78% | -14.06% | -3.51% |
May. 28 | Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD | CI |
May. 28 | Opthea Completes Enrollments in COAST, ShORe Trials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.51% | 260M | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+37.40% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- OPT Stock
- News Opthea Limited
- Opthea Receives AU$9 Million Tax Rebate for Fiscal Year 2023